I prefer to think along the lines of a quarterly update, as promised, and a week early , is all this is. If they have as much in the pipeline as this interview says, they will be raising at 8-9c towards the end of the year, not now. The seller seems to have gone now, and the price is going back to fairer value in the threes. But imo it should be in the fours, ready to rerate.
Introduction from the Phylogica Investor Relations team, page-3
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
